REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Coherus BioSciences Inc. (CHRS) on Wednesday reported a loss of $10.8 million in its third quarter.
On a per-share basis, the Redwood City, California-based company said it had a loss of 9 cents. Losses, adjusted for stock option expense and non-recurring costs, came to 1 cent per share.
The drug developer posted revenue of $70.8 million in the period, surpassing Street forecasts. Four analysts surveyed by Zacks expected $56.9 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CHRS at https://www.zacks.com/ap/CHRS
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
